Triple Negative Breast Neoplasms
Item
triple negative breast cancer
boolean
C3539878 (UMLS CUI [1])
Estrogen Receptors Percentage | Progesterone Receptors Percentage | Human epidermal growth factor receptor negative
Item
er/pr <10% and her negative per current asco/cap guidelines
boolean
C0034804 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0034833 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C4087185 (UMLS CUI [3])
TNM Breast tumor staging
Item
stages i-iv
boolean
C0474926 (UMLS CUI [1])
Age
Item
any age at diagnosis
boolean
C0001779 (UMLS CUI [1])
Diagnosis Timespan
Item
patient must be within 5 years of diagnosis
boolean
C0011900 (UMLS CUI [1,1])
C0872291 (UMLS CUI [1,2])
Patient eligible for clinical trial Independent of Genetic testing
Item
eligible regardless of genetic testing status
boolean
C1302261 (UMLS CUI [1,1])
C0332291 (UMLS CUI [1,2])
C0679560 (UMLS CUI [1,3])
Genetic testing Recommended
Item
genetic testing recommended for patients meeting nccn and medicare guidelines
boolean
C0679560 (UMLS CUI [1,1])
C0034866 (UMLS CUI [1,2])
Germ-Line Mutation Carrier
Item
germline mutation carriers
boolean
C0206530 (UMLS CUI [1,1])
C2985478 (UMLS CUI [1,2])
HBOC Genes | BRCA gene | PTEN gene | TP53 gene | PALB2 gene | Patient eligible for clinical trial Independent of Cancer site
Item
patients with deleterious or uncertain mutations in hboc genes (brca, pten, p53,-palb2 etc) are eligible regardless of type/site of cancer
boolean
C0677776 (UMLS CUI [1,1])
C0017337 (UMLS CUI [1,2])
C0596223 (UMLS CUI [2])
C0694888 (UMLS CUI [3])
C0079419 (UMLS CUI [4])
C1835898 (UMLS CUI [5])
C1302261 (UMLS CUI [6,1])
C0332291 (UMLS CUI [6,2])
C0872338 (UMLS CUI [6,3])
Healthy Volunteers Mutation | Patient eligible for clinical trial
Item
healthy patients harboring mutations also eligible
boolean
C1708335 (UMLS CUI [1,1])
C0026882 (UMLS CUI [1,2])
C1302261 (UMLS CUI [2])
Time limit Absent | Cancer diagnosis | Enrollment
Item
there is no time limit from the time of diagnosis of cancer and enrollment.
boolean
C0332186 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0920688 (UMLS CUI [2])
C1516879 (UMLS CUI [3])
Patient eligible for clinical trial Independent of Cancer History
Item
eligible regardless of personal history of cancer
boolean
C1302261 (UMLS CUI [1,1])
C0332291 (UMLS CUI [1,2])
C1512706 (UMLS CUI [1,3])
Exclusion Criteria
Item
exclusion criteria include:
boolean
C0680251 (UMLS CUI [1])
Triple Negative Breast Neoplasm Previous
Item
triple negative breast cancer -patient is not within five years of diagnosis
boolean
C3539878 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Germ-Line Mutation Carrier
Item
germline mutation carriers:
boolean
C0206530 (UMLS CUI [1,1])
C2985478 (UMLS CUI [1,2])
HBOC Mutation Singular | Polymorphism
Item
patient only carries a hboc mutation that is classified as "polymorphism" of "favor polymorphism"
boolean
C0677776 (UMLS CUI [1,1])
C0026882 (UMLS CUI [1,2])
C0205171 (UMLS CUI [1,3])
C1882417 (UMLS CUI [2])